16425530ACTIVE
Incorporated: 2025-05-02
SIC: 72110
Last updated: 29 May 2026
TollCyto Therapeutics develops precision‑engineered oncolytic herpesvirus therapies, including HSV5‑ Sign up to read more
No filings found for this company.
Companies with the most similar business descriptions.
Accounts not filed